Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

394.14
Delayed Data
As of Mar 29
 +11.59 / +3.03%
Today’s Change
325.35
Today|||52-Week Range
452.96
+7.37%
Year-to-Date

Today’s Trading

Previous close382.55
Today’s open382.46
Day’s range382.06 - 401.21
Volume1,945,473
Average volume (3 months)954,591
Market cap$41.8B
Dividend yield--
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+14.93%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+18.44%
P/E ratio51.2
Price/Sales8.79
Price/Book9.39

Competitors

 Today’s
change
Today’s
% change
SHPGShire+0.79+0.45%
INCYIncyte Corp-0.20-0.14%
BAXBaxter International...+0.09+0.17%
ALXNAlexion Pharmaceutic...+2.19+1.85%
Data as of 03/29/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts


Search for Jobs